Oragenics Inc (NYSE MKT LLC:OGEN)

0.76
Delayed Data
As of May 29
 +0.0101 / +1.35%
Today’s Change
0.70
Today|||52-Week Range
2.75
-14.58%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues1.4M1.3M1.0M939.9K
 
 
 
 
 
Cost of Goods Sold634.1K878.5K343.4K341.9K
 
 
 
 
 
Depreciation And Amortization79.5K75.2K76.5K27.7K
 
 
 
 
 
 
Operating ExpensesGross Income730.8K378.1K612.4K570.3K
 
 
 
 
 
General Expenses8.1M12.8M16.8M6.4M
 
 
 
 
 
Research And Development2.4M7.8M9.3M3.1M
 
 
 
 
 
Total Operating Expenses8.8M13.8M17.2M6.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.3M-12.4M-16.2M-5.8M
 
 
 
 
 
Interest Expense On Debt332.3K655.6K17.5K4.0K
 
 
 
 
 
Other Expenses-1.2K-17.8K135.5K-6.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.7M-13.1M-16.1M-5.8M
 
 
 
 
 
Net Income-7.7M-13.1M-16.1M-5.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS5.7M17.7M28.8M36.2M
 
 
 
 
 
Shares To Calculate EPS Diluted5.7M17.7M28.8M36.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.34-$0.74-$0.56-$0.16
 
 
 
 
 
EPS Diluted-$1.34-$0.74-$0.56-$0.16
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account